Remove 2023 Remove Healthcare Remove Pharma
article thumbnail

CPHI Pharma Awards 2023 finalists announced

European Pharmaceutical Review

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Are you coming to the CPHI Barcelona 2023?

Pharma 119
article thumbnail

Do Healthcare Providers Really Want to Go Back to In-person Meetings?

Impetus Digital

It is easy to assume that healthcare providers (HCPs) all want to go back to in-person meetings after having been confined to Zoom and Microsoft Teams meetings during the pandemic years. They asked the very important question: what do HCPs really prefer when it comes to Pharma-sponsored small-group meetings such as advisory boards?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

JPM24: Pfizer CEO promises 'year of execution' after recent struggles, Seagen buyout

Fierce Pharma

Pfizer knows it had a bad year in 2023. Pfizer knows it had a bad year in 2023. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches. Speaking to reporters at the 2024 J.P.

article thumbnail

What Will the Future Hold for Pharma Marketing in 2025?

eMediWrite

AI-Driven Personalization in Doctor Engagement* Artificial Intelligence (AI) is transforming the way pharmaceutical brands interact with healthcare professionals (HCPs). Real-world evidence (RWE) enables pharma brands to craft more targeted marketing messages. Influencer collaborations with healthcare professionals to build trust.

article thumbnail

Pharma firepower, M&A surge last year bode well for dealmaking prospects in 2024: EY

Fierce Pharma

Morgan Healthcare Conference. | The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said. Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P.

article thumbnail

How Counterfeit Medicines Challenge Pharma Sales in Malaysia

Contrarian Sales Techniques

It’s a reality for many of us in pharma sales in Malaysia. In 2023, the Ministry of Health reported that over 1,600 websites selling illegal pharmaceutical products were blocked, highlighting the scale of the issue. Generics are a vital part of the healthcare system, offering safe and cost-effective alternatives.

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) in person again, believing that’s what most KOLs want.

Pharma 92